If you had looked at Lemonade on 1 January 2026, seen the bullish Q3 2024 report arguing for a long term turnaround, and still hesitated, the skipped decision would have felt uncomfortable at first. Holding Lemonade from the start of the year would have meant a 40.2% loss, including dividends. With today’s results and guidance in hand, the real puzzle is which early assumptions about growth, margins or AI risk you would want to examine most closely.
The easy part of this move is behind Lemonade. Zero in on 29 high quality undervalued stocks for companies trading below our estimates.
The Two Futures Lemonade Investors Were Arguing About
The shares cost US$71.18 at the start of the period, so anyone looking at Lemonade then had to decide which story felt more realistic.
The optimistic case pointed to a Fair Value of US$77.14, a rough guide to what the stock might be worth if the Q3 2024 momentum and a 25.2% revenue growth assumption held, with profit margin eventually reaching 15.0% over a 5 year stretch.
The cautious narrative saw Fair Value at US$45.12 and treated the 44.9% projected revenue growth as fragile, given concerns that AI driven expansion, regulatory scrutiny and rising claim costs could prevent profit margin from reaching 11.0% on a 3 year view.
What The Results Changed For Lemonade
Lemonade’s Q2 2026 report showed revenue of US$294.4 million versus US$164.1 million a year earlier, with the loss at US$43.4 million against US$43.9 million and net margin improving from 26.8% to 14.7%. That tilt toward better profitability supported parts of the optimistic case, but the business still reporting losses kept the turnaround story unresolved.
The lesson is clear. When a thesis leans on future profitability, track net margin and absolute profit side by side, and test whether each period actually moves those figures toward the target.
What Lemonade’s Drop Is Asking You To Believe
Lemonade now trades at US$45.41 from the start of the year, after a 40.2% loss. The selected Narrative’s Fair Value sits above the current price, based on the idea that AI driven underwriting and broader product coverage can lift efficiency and support better economics over time.
The real test for anyone buying Lemonade today is whether that AI centric playbook can keep improving loss ratios and operating margins at a pace that justifies paying for a recovery after such a steep fall.
"Lemonade's rapid adoption and integration of in-house AI-driven underwriting platforms and proprietary data provide a sustainable long-term efficiency advantage, leading to continued improvement in underwriting accuracy, loss ratios, operating margins, and net earnings."
That disagreement has a full argument behind it. → Uncover the higher Fair Value this Narrative argues for
Before The Next Story Makes Headlines
Passing on this one could have spared you a loss. Where might you find the opposite surprise? Start looking for companies whose prices leave room for a better outcome than investors expect. These three trade below our estimated value.
- Company 1 - 33% below our estimate - sells a tightly integrated AI computing stack customers struggle to replicate elsewhere.
- Company 2 - 24% below our estimate - becomes the central metering layer enterprises rely on to track distributed AI usage.
- Company 3 - 35% below our estimate - wins complex subsea iEPCI work that accelerates brownfield tiebacks and follow-on services.
Three companies from the same screener. Open the full list of 26 financially solid companies →
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com